In the News
October 12, 2020
Transforming the Treatment of Cancer with Oncolytic Viruses
Decision Resources Group "Conversations in Health"
June 11, 2020
Vyriad CEO Stephen Russell discusses neutralizing antibody testing
Myeloma Crowd Radio
May 22, 2020
University of Minnesota’s Infectious Disease Center Urges Better Use of COVID-19 Testing
Star Tribune
May 13, 2020
Rochester Scientists Develop First-of-its-Kind Antibody Test to Detect Protective Immunity
Med City Beat
March 4, 2020
Dr. Stephen Russell Participates in “Creating a Cluster of Innovation in Rochester” Podcast
Finance & Commerce
November 21, 2019
Rochester Cancer-Therapy Firm to Collaborate with Drugmaker on Melanoma Treatment
Star Tribune
November 6, 2019
Rochester Biotech Firm Strikes ‘Significant’ Deal with Drug Maker
Rochester Post-Bulletin
January 17, 2019
State of the Art Cancer Therapeutics Manufacturing Headquarters Celebrates Grand Opening in Rochester Next Week
Rochester Rising
July 27, 2018
Vyriad Expands Phase 1 Trial to Test Voyager-V1 in Combination with Bevencio for Colorectal Cancer
Immuno-Oncology News
June 11, 2018
Mayo Clinic patient treated by massive measles dose still cancer-free 5 years later
Star Tribune
March 28, 2018
Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials
Twin Cities Business